{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:32:22Z","timestamp":1781897542588,"version":"3.54.5"},"reference-count":61,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,7,23]]},"DOI":"10.3233\/jad-190099","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T12:59:24Z","timestamp":1561467564000},"page":"573-585","source":"Crossref","is-referenced-by-count":18,"title":["AAV9-Mediated Cdk5 Inhibitory Peptide Reduces Hyperphosphorylated Tau and Inflammation and Ameliorates Behavioral Changes Caused by Overexpression of p25 in the Brain"],"prefix":"10.1177","volume":"70","author":[{"given":"Miaojing","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China"},{"name":"Department of Neurology, the First Affiliated Hospital of Hainan Medical University, Haikou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingwei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China"},{"name":"Department of Neurology, the First People\u2019s Hospital of Shunde, Southern Medical University, Guangzhou, Guangdong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Ting","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Behavioral Medicine and Psychiatry and Department of Physiology and Pharmacology, West Virginia University Health Sciences Center, Morgantown, WV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-190099_ref1","doi-asserted-by":"crossref","first-page":"13383","DOI":"10.1016\/S0021-9258(18)42222-3","article-title":"Purification and characterization of a novel proline-directed protein kinase from bovine brain","volume":"267","author":"Lew","year":"1992","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190099_ref2","doi-asserted-by":"crossref","first-page":"26897","DOI":"10.1074\/jbc.270.45.26897","article-title":"An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator","volume":"270","author":"Tang","year":"1995","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190099_ref3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-cellbio-092910-154023","article-title":"Cyclin-dependent kinases in brain development and disease","volume":"27","author":"Su","year":"2011","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.3233\/JAD-190099_ref4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/35096019","article-title":"A decade of CDK5","volume":"2","author":"Dhavan","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.3233\/JAD-190099_ref5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1101\/gad.10.7.816","article-title":"The cdk5\/p35 kinase is essential for neurite outgrowth during neuronal differentiation","volume":"10","author":"Nikolic","year":"1996","journal-title":"Genes Dev"},{"key":"10.3233\/JAD-190099_ref6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/35012636","article-title":"Neurotoxicity induces cleavage of p35 to p25 by calpain","volume":"405","author":"Lee","year":"2000","journal-title":"Nature"},{"key":"10.3233\/JAD-190099_ref7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"key":"10.3233\/JAD-190099_ref8","doi-asserted-by":"crossref","first-page":"24057","DOI":"10.1074\/jbc.273.37.24057","article-title":"p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway","volume":"273","author":"Patrick","year":"1998","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190099_ref9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jnr.10116","article-title":"Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35","volume":"67","author":"Amin","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-190099_ref10","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/j.1471-4159.2008.05500.x","article-title":"Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes","volume":"106","author":"Asada","year":"2008","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-190099_ref11","doi-asserted-by":"crossref","first-page":"17166","DOI":"10.1074\/jbc.M907757199","article-title":"Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25","volume":"275","author":"Kusakawa","year":"2000","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190099_ref12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0896-6273(03)00259-9","article-title":"Cdk5 is a key factor in tau aggregation and tangle formation in vivo","volume":"38","author":"Noble","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JAD-190099_ref13","first-page":"1465","article-title":"Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5","volume":"147","author":"Brion","year":"1995","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-190099_ref14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0006-8993(00)02086-2","article-title":"Cyclin-dependent kinase 5 (Cdk5) associated with Lewy bodies in diffuse Lewy body disease","volume":"862","author":"Takahashi","year":"2000","journal-title":"Brain Res"},{"key":"10.3233\/JAD-190099_ref15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s004010050687","article-title":"p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson\u2019s disease","volume":"94","author":"Nakamura","year":"1997","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-190099_ref16","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1523\/JNEUROSCI.3237-08.2008","article-title":"Dopaminergic and glutamatergic signaling crosstalk in Huntington\u2019s disease neurodegeneration: The role of p25\/cyclin-dependent kinase 5","volume":"28","author":"Paoletti","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-190099_ref17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000074623","article-title":"Cyclin-dependent kinase 5 in amyotrophic lateral sclerosis","volume":"12","author":"Nguyen","year":"2003","journal-title":"Neurosignals"},{"key":"10.3233\/JAD-190099_ref18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0896-6273(01)00268-9","article-title":"Deregulation of Cdk5 in a mouse model of ALS: Toxicity alleviated by perikaryal neurofilament inclusions","volume":"30","author":"Nguyen","year":"2001","journal-title":"Neuron"},{"key":"10.3233\/JAD-190099_ref19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1037\/a0023167","article-title":"ROCK inhibition prevents tau hyperphosphorylation and p25\/CDK5 increase after global cerebral ischemia","volume":"125","author":"Castro-Alvarez","year":"2011","journal-title":"Behav Neurosci"},{"key":"10.3233\/JAD-190099_ref20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1474-9726.2009.00536.x","article-title":"Neurodegeneration in an Abeta-induced model of Alzheimer\u2019s disease: The role of Cdk5","volume":"9","author":"Lopes","year":"2010","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-190099_ref21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1096\/fj.12-217497","article-title":"A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer\u2019s disease phenotypes in model mice","volume":"27","author":"Shukla","year":"2013","journal-title":"FASEB J"},{"key":"10.3233\/JAD-190099_ref22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0896-6273(03)00627-5","article-title":"Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles","volume":"40","author":"Cruz","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JAD-190099_ref23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1523\/JNEUROSCI.3593-12.2013","article-title":"Specific inhibition of p25\/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo","volume":"33","author":"Sundaram","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-190099_ref24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1432-1033.1997.t01-2-00527.x","article-title":"Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5","volume":"243","author":"Meijer","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.3233\/JAD-190099_ref25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.emboj.7600441","article-title":"A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons","volume":"24","author":"Zheng","year":"2005","journal-title":"EMBO J"},{"key":"10.3233\/JAD-190099_ref26","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1046\/j.1432-1033.2002.03133.x","article-title":"A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells","volume":"269","author":"Zheng","year":"2002","journal-title":"Eur J Biochem"},{"key":"10.3233\/JAD-190099_ref27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/biot.200700057","article-title":"Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5","volume":"2","author":"Kesavapany","year":"2007","journal-title":"Biotechnol J"},{"key":"10.3233\/JAD-190099_ref28","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1096\/fj.201700064R","article-title":"Adeno-associated viral 9-mediated Cdk5 inhibitory peptide reverses pathologic changes and behavioral deficits in the Alzheimer\u2019s disease mouse model","volume":"31","author":"He","year":"2017","journal-title":"FASEB J"},{"key":"10.3233\/JAD-190099_ref29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fnagi.2018.00162","article-title":"Cdk5 inhibitory peptide prevents loss of dopaminergic neurons and alleviates behavioral changes in an MPTP induced Parkinson\u2019s disease mouse model","volume":"10","author":"He","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-190099_ref30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-160191","article-title":"Neurodegeneration-like pathological and behavioral changes in an AAV9-mediated p25 overexpression mouse model","volume":"53","author":"Zhou","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190099_ref31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbadis.2017.10.022","article-title":"Disruption of AT-hook 1 domain in MeCP2 protein caused behavioral abnormality in mice","volume":"1864","author":"Xu","year":"2018","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-190099_ref32","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stem.2011.09.002","article-title":"Direct lineage conversion of terminally differentiated hepatocytes to functional neurons","volume":"9","author":"Marro","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JAD-190099_ref33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.stem.2011.07.014","article-title":"Conversion of mouse and human fibroblasts into functional spinal motor neurons","volume":"9","author":"Son","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JAD-190099_ref34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature10202","article-title":"Induction of human neuronal cells by defined transcription factors","volume":"476","author":"Pang","year":"2011","journal-title":"Nature"},{"key":"10.3233\/JAD-190099_ref35","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1523\/JNEUROSCI.5177-11.2012","article-title":"Cdk5\/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration","volume":"32","author":"Sundaram","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-190099_ref36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00702-018-1880-6","article-title":"Neuroinflammation in neurodegeneration: Role in pathophysiology, therapeutic opportunities and clinical perspectives","volume":"125","author":"Dorothee","year":"2018","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-190099_ref37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2353\/ajpath.2008.070693","article-title":"Neurodegeneration and neuroinflammation in cdk5\/p25-inducible mice: A model for hippocampal sclerosis and neocortical degeneration","volume":"172","author":"Muyllaert","year":"2008","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-190099_ref38","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1073\/pnas.040577797","article-title":"Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5","volume":"97","author":"Ahlijanian","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-190099_ref39","first-page":"119","article-title":"Adeno-associated virus as a gene therapy vector: Vector development, production and clinical applications","volume":"99","author":"Grieger","year":"2005","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"10.3233\/JAD-190099_ref40","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/978-1-4614-3209-8_86","article-title":"Advances in AAV vector development for gene therapy in the retina","volume":"801","author":"Day","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"10.3233\/JAD-190099_ref41","doi-asserted-by":"crossref","first-page":"974819","DOI":"10.1155\/2013\/974819","article-title":"Systemic delivery of tyrosine-mutant AAV vectors results in robust transduction of neurons in adult mice","volume":"2013","author":"Iida","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.3233\/JAD-190099_ref42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fnmol.2014.00081","article-title":"Intravenous AAV9 efficiently transduces myenteric neurons in neonate and juvenile mice","volume":"7","author":"Gombash","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-190099_ref43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainresbull.2017.05.006","article-title":"Cyclin dependent kinase 5: A novel avenue for Alzheimer\u2019s disease","volume":"132","author":"Bhounsule","year":"2017","journal-title":"Brain Res Bull"},{"key":"10.3233\/JAD-190099_ref44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0014-5793(02)03487-7","article-title":"Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3\u03b2","volume":"530","author":"Liu","year":"2002","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-190099_ref45","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1016\/j.febslet.2006.10.033","article-title":"PKA modulates GSK-3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners","volume":"580","author":"Liu","year":"2006","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-190099_ref46","first-page":"1138","article-title":"Quercetin inhibits okadaic acid-induced tau protein hyperphosphorylation through the Ca2+calpainp25CDK5 pathway in HT22 cells","volume":"41","author":"Shen","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.3233\/JAD-190099_ref47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fnmol.2014.00065","article-title":"Physiological and pathological phosphorylation of tau by Cdk5","volume":"7","author":"Kimura","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-190099_ref48","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.lfs.2010.02.009","article-title":"Increased expression of cdk5\/p25 in N2a cells leads to hyperphosphorylation and impaired axonal transport of neurofilament proteins","volume":"86","author":"Zhou","year":"2010","journal-title":"Life Sci"},{"key":"10.3233\/JAD-190099_ref49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jemt.22319","article-title":"Tau binds ATP and induces its aggregation","volume":"77","author":"Farid","year":"2014","journal-title":"Microsc Res Tech"},{"key":"10.3233\/JAD-190099_ref50","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.4103\/0366-6999.220313","article-title":"Tau-mediated neurodegeneration and potential implications in diagnosis and treatment of Alzheimer\u2019s disease","volume":"130","author":"Wu","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"10.3233\/JAD-190099_ref51","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1007\/s12035-015-9369-x","article-title":"The role of Cdk5 in Alzheimer\u2019s disease","volume":"53","author":"Liu","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-190099_ref52","doi-asserted-by":"crossref","first-page":"e0136950","DOI":"10.1371\/journal.pone.0136950","article-title":"Enhancement of BACE1 activity by p25\/Cdk5-mediated phosphorylation in Alzheimer\u2019s disease","volume":"10","author":"Song","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190099_ref53","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1038\/tp.2011.27","article-title":"Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer\u2019s disease brain","volume":"1","author":"Rao","year":"2011","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-190099_ref54","doi-asserted-by":"crossref","first-page":"423 e421","DOI":"10.1016\/j.neurobiolaging.2010.09.018","article-title":"Reactive astrocytes give neurons less support: Implications for Alzheimer\u2019s disease","volume":"33","author":"Steele","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-190099_ref55","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","article-title":"Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway","volume":"23","author":"Li Y","year":"2003","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-190099_ref56","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.2353\/ajpath.2008.080528","article-title":"Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice","volume":"173","author":"Janelsins","year":"2008","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-190099_ref57","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1742-2094-7-56","article-title":"LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice","volume":"7","author":"Lee","year":"2010","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-190099_ref58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.exger.2016.12.006","article-title":"A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer\u2019s disease","volume":"94","author":"Barron","year":"2017","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-190099_ref59","doi-asserted-by":"crossref","first-page":"12318","DOI":"10.1074\/jbc.272.19.12318","article-title":"Cyclin-dependent kinase 5 (Cdk5) activation domain of neuronal Cdk5 activator. Evidence of the existence of cyclin fold in neuronal Cdk5a activator","volume":"272","author":"Tang","year":"1997","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190099_ref60","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jmb.2010.06.040","article-title":"Structural and dynamic determinants of ligand binding and regulation of cyclin-dependent kinase 5 by pathological activator p25 and inhibitory peptide CIP","volume":"401","author":"Cardone","year":"2010","journal-title":"J Mol Biol"},{"key":"10.3233\/JAD-190099_ref61","doi-asserted-by":"crossref","first-page":"34202","DOI":"10.1074\/jbc.M110.134643","article-title":"A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation","volume":"285","author":"Zheng","year":"2010","journal-title":"J Biol Chem"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-190099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:10:06Z","timestamp":1777371006000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-190099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,23]]},"references-count":61,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-190099","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,23]]}}}